CD4 and breast benign neoplasm: Moreover, in our previous study, we found that the proportion of CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer was higher than that in the peripheral blood of patients with benign breast tumors and healthy volunteers; the proportion of CD4+CD25+Tcells was directly related to tumor size [23].